Request Demo
Recent blog posts
Latest Hotspot
8 min read
NCT07688213 VG-3927 Alzheimer Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07688213 clinical trial report covering VG-3927, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07688772 Drotokibart Rhinitis, Allergic, Seasonal Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07688772 clinical trial report covering Drotokibart, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07687914 Palverafusp α Advanced Hepatocellular Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07687914 clinical trial report covering Palverafusp α, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07686380 Nogapendekin alfa inbakicept-pmln Recurrent Prostate Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07686380 clinical trial report covering Nogapendekin alfa inbakicept-pmln, Phase 2, endpoints, sponsor, geography, readout timing and development white spa
Latest Hotspot
8 min read
JPRN-jRCT2031260234 Cancer (Breakthru Medicin) Microsatellite instability-high colorectal cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
JPRN-jRCT2031260234 clinical trial report covering Cancer (Breakthru Medicin), Phase 3, endpoints, sponsor, geography, readout timing and development white sp
Latest Hotspot
8 min read
NCT07686770 Genakumab Mucocutaneous Lymph Node Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07686770 clinical trial report covering Genakumab, Phase 2/3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07686926 Tislelizumab Advanced Esophageal Squamous Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07686926 clinical trial report covering Tislelizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07688070 Verapamil Hydrochloride Glucose Intolerance Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07688070 clinical trial report covering Verapamil Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07686081 Ponesimod Colitis, Ulcerative Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07686081 clinical trial report covering Ponesimod, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07686263 Xanomeline Tartrate/Trospium Chloride Schizophrenia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07686263 clinical trial report covering Xanomeline Tartrate/Trospium Chloride, Phase 3, endpoints, sponsor, geography, readout timing and development white
Latest Hotspot
8 min read
NCT07686367 Brenetafusp Synovial Sarcoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07686367 clinical trial report covering Brenetafusp, Phase 2, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07686120 Baxdrostat Hypertension Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
21 July 2026
NCT07686120 clinical trial report covering Baxdrostat, Phase 3, endpoints, sponsor, geography, readout timing and development white space.